RESPIRATORY ALKALOSIS
DEFINITION
A condition due to a primary fall in arterial carbon dioxide partial
pressure (typically to 20 to 25 mmHg) where blood pH is elevated and
plasma bicarbonate concentration decreased (typically by < 4 mEq/L).
It is caused by loss of CO2 due to hyperventilation.
Respiratory alkalosis is not life-threatening.
TOXIC CAUSES
Salicylates (early stage).
NON-TOXIC CAUSES
Anxiety and hyperventilation
Fever
Gram-negative septicaemia
Hepatic cirrhosis
Hepatic coma
Hypoxaemia
Overventilation of patients with assisted respiration.
Primary CNS disorders
CLINICAL FEATURES
The priniciple clinical feature is hyperventilation. Severe cases may
result in tetany with Chvostek's and Trousseau's signs, circumoral
paraesthesiae, acroparaesthesiae, and carpopedal cramps due to reduced
serum ionized calcium concentration.
RELEVANT INVESTIGATIONS
Arterial blood gas analysis (pH, bicarbonate)
Ionized calcium concentration
Serum salicylate concentration
TREATMENT
The primary treatment of salicylate-induced respiratory alkalosis is
treatment of the primary condition (salicylate toxicity).
Anxiety-induced respiratory alkalosis is best treated with
reassurance. Rebreathing expired carbon dioxide from a paper (not
plastic!) bag may be helpful, but might be dangerous in patients with
CNS disturbances. Hypoxaemic patients need O2 enrichment of inspired
air. Overventilation on mechanical respirators should be corrected or
dead space added.
CLINICAL COURSE AND MONITORING
The acute condition usually subsides quickly with proper management.
Patients must be observed for recurrences. Underlying neurological or
hepatic disturbances need specialist treatment.
LONG-TERM COMPLICATIONS
None.
AUTHOR(S)/REVIEWERS
Author: Dr Janusz Szajewski, Warsaw Poisons Control Centre,
Warszawa, Poland.
Peer Review: Rio de Janeiro 9/97: J.N. Bernstein, E. Birtanov,
H. Hentschel, T.J. Meredith, Y. Ostapenko, P. Pelclova,
C.P. Snook, J. Szajewski.
London 3/98: T. Della Puppa, T.J. Meredith, L. Murray,
A.Nantel.